Scientists at Nagoya University in Japan have hit a major milestone in regenerative medicine, successfully transplanting lab-grown human pituitary tissue into a primate for the first time. The team created organoids — tiny lab-made tissue masses that mimic real organs — from human stem cells, loaded with cells that produce ACTH, the hormone that tells the adrenal glands to release cortisol. When transplanted into a macaque monkey whose pituitary had been surgically removed, the organoids functioned for six weeks, raising ACTH and cortisol levels and slowing the severe weight loss caused by hormone deficiency.

Before the primate experiment, the team validated the approach in mice, where the organoids produced ACTH for over six months and meaningfully extended the animals' lifespans — with no tumors or abnormal cell growth detected. In the macaque, surviving transplanted cells were still found three months post-transplant, despite the immune challenges of cross-species transplantation.

By the Numbers

• Organoids produced ACTH for 6+ months in mice, extending their lifespans vs. untreated controls
• Transplanted tissue remained functional for 6 weeks in the primate model
• Surviving cells were still detected 3 months after transplantation in the macaque
• 0 cases of stray organoid tissue found in lungs or liver — a key safety checkpoint

Why it matters: Patients with hypopituitarism currently rely on daily hormone pills that can't replicate the body's natural fluctuations, leaving them at elevated risk of sudden death during periods of stress. A transplantable, hormone-producing tissue could offer a far more physiological — and potentially life-saving — alternative. Further studies are planned to improve graft longevity and refine immune suppression strategies.